This is therefore a comparing of the analyst recommendations, profitability, institutional ownership, risk, dividends, earnings and valuation in Intec Pharma Ltd. (NASDAQ:NTEC) and Akari Therapeutics Plc (NASDAQ:AKTX). The two are both Biotechnology companies that compete with one another.
Table 1 shows the top-line revenue, earnings per share and valuation for Intec Pharma Ltd. and Akari Therapeutics Plc.
Table 2 represents Intec Pharma Ltd. (NASDAQ:NTEC) and Akari Therapeutics Plc (NASDAQ:AKTX)’s return on assets, net margins and return on equity.
Institutional and Insider Ownership
The shares of both Intec Pharma Ltd. and Akari Therapeutics Plc are owned by institutional investors at 39.64% and 5.6% respectively. Insiders held roughly 11.81% of Intec Pharma Ltd.’s shares. Insiders Comparatively, held 57.08% of Akari Therapeutics Plc shares.
Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.